Bergamot Polyphenol Extract Reduces Hepatocyte Neutral Fat by Increasing Beta-Oxidation

Area of Science:

• Hepatology
• Molecular Biology
• Nutraceuticals

Background:

• Bergamot polyphenolic fraction (PF) shows promise in combating liver steatosis.
• The precise mechanisms behind bergamot's beneficial effects on fatty liver disease are not fully understood.
• Investigating bergamot PF's impact on liver cells is crucial for understanding its therapeutic potential.

Purpose of the Study:

• To elucidate the molecular mechanisms by which bergamot PF influences liver steatosis.
• To evaluate the efficacy of bergamot PF in both 2D and 3D hepatocyte culture models.
• To determine the effect of bergamot PF on intracellular lipid content and related gene expression.

Main Methods:

• Utilized 2D and 3D cell cultures, including rat hepatocytes, human hepatoma cells, and primary human hepatocytes.
• Assessed intracellular lipid levels following bergamot PF incubation.
• Analyzed the expression of key genes involved in beta-oxidation (Acox1, Pparα, Ucp2) and lipophagy (Atg7).

Main Results:

• Bergamot PF significantly decreased intracellular lipid content in 2D hepatocyte cultures.
• Increased expression of beta-oxidation genes (Acox1, Pparα, Ucp2) and lipophagy gene (Atg7) was observed.
• These lipid-lowering effects were confirmed in 3D spheroid and organoid models.

Conclusions:

• Bergamot PF effectively reduces neutral lipid accumulation in hepatocytes.
• The mechanism involves the upregulation of intracellular beta-oxidation pathways.
• Bergamot PF demonstrates therapeutic potential for managing fatty liver disease.